News & Events

News

Covid 19

Members of the Minnesota COVID Ethics Collaborative (MCEC) Publish "Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic”

June 15, 2020

Members of the Minnesota COVID Ethics Collaborative (MCEC) and key partners in the Minnesota Department of Health (MDH) have published a new article in Mayo Clinic Proceedings on the development of an ethical framework for Minnesota’s allocation of remdesivir, an experimental drug used to treat COVID-19. The authors illuminate the “real-time” bioethics process used to cope with urgent need, resource scarcity, and a still-emerging evidence base. The article can help other states and agencies determine how to allocate remdesivir. MCEC is co-led by Profs. Debra DeBruin at the University’s Center for Bioethics and Susan M. Wolf at the Consortium. 

New England Journal of Medicine logo

Prof. Rachel Hardeman on Structural Racism in Health Care

June 12, 2020

In an article on “Stolen Breaths” in the New England Journal of Medicine, Professor Rachel Hardeman and co-authors powerfully argue that “for the health of the black community and, in turn, the health of the nation, we address the social, economic, political, legal, educational, and health care systems that maintain structural racism.” The authors recommend five practices for health care systems to implement. Professor Hardeman is a faculty member in the University of Minnesota’s School of Public Health and an Affiliate Faculty Member in the Center for Bioethics, a Consortium Member Center. To read the article, see the New England Journal of Medicine website.

Whole brain scan

Prof. Francis Shen Offers Insights on Neurolaw in ABA Journal

June 10, 2020

The American Bar Association Journal recently spotlighted Professor Francis Shen’s work in a feature story about investment in neurolaw. Professor Shen’s Neurolaw Lab at the University of Minnesota Law School studies a range of issues including dementia, brain injury, and the law. He is also leading research on the challenges raised by emerging neuroimaging technology and is an Affiliate Faculty Member in the Consortium. Read more at the ABA Journal website.  

Stem cell

The Ethics of Using Chimeras for Organ Transplants

June 1, 2020

In a paper recently published in Stem Cell Reports, Dr. Daniel Garry of the Stem Cell Institute and co-authors discuss ethical issues raised by the use of chimeras for research purposes and human organ transplants. The article focuses on pig-human chimeras to generate blood vessels and blood products for use in humans. Progress in this field can help address the persistent gap between the number of people in need of a transplant and available organs. The Stem Cell Institute is a Consortium member center. Information on the paper is posted on the Stem Cell Institute website; read the paper here

COVID-19

CIDRAP Proposes Strategic Approach to COVID-19 Testing

May 22, 2020

The Center for Infectious Disease Research and Policy (CIDRAP) has published “Smart testing for COVID-19 virus and antibodies,” the third in a series of reports focused on the COVID-19 pandemic. The report includes a proposal for a smart testing framework and offers considerations for policy makers, public health agencies, hospital administrators, and the public. CIDRAP also recommends that the U.S. Secretary of Health and Human Services (HHS) appoint a blue-ribbon panel of national experts by July 1, and that HHS review and evaluate the public health response of governments from around the globe in order to determine best practices for the U.S. response. CIDRAP is a Consortium member center. More information is available on the CIDRAP website here; view all CIDRAP reports on the COVID-19 pandemic here. Read a Star Tribune article about the report and other issues facing COVID-19 testing here.

Covid & people

Minnesota COVID Ethics Collaborative Develops Ethical Framework for Remdesivir Allocation

May 19, 2020

Remdesivir is the only drug found so far to potentially shorten recovery time from COVID-19. On May 1, the U.S. Food and Drug Administration authorized emergency use of this antiviral medication for patients with severe disease. The Minnesota Department of Health has worked with the Minnesota COVID Ethics Collaborative (MCEC) to create an ethical framework for distributing the state’s allocation of the drug. MCEC is co-led by Profs. Debra DeBruin and Susan M. Wolf. DeBruin is Interim Director of the Center for Bioethics, a Consortium member center, and Wolf is Chair of the Consortium. Read the “Ethical Framework for May 2020 Allocation of Remdesivir in the COVID-19 Pandemic here. More information about the challenges of allocating remdesiver is available here

Pages